NEW YORK – U.S. stocks closed sharply lower on Tuesday, April 8, 2025, as intense volatility persisted throughout the trading day, fueled by escalating concerns over the potential economic fallout from sweeping tariffs set to be imposed by the Trump administration. A significant late-session slide effectively erased substantial earlier gains, sending major indices into negative territory.
The market reaction underscored deep investor anxiety surrounding the tariffs, which were scheduled to take effect at midnight. The Dow Jones Industrial Average ultimately fell 0.8%, a decline of approximately 300 points, despite having soared by nearly 1,500 points earlier in the session. The S&P 500 experienced a 1.6% drop by the close, while the technology-heavy Nasdaq Composite finished down 2.2%; both indices had enjoyed gains exceeding 4% during earlier trading.
The Tariff Threat Escalates
Tuesday’s turbulent trading session followed a similarly volatile day on Monday and marked the continuation of a challenging period for equities. U.S. stocks had endured their worst week in five years during the previous week, largely in anticipation of President Trump’s planned tariffs. These measures target almost every country, with particularly high levies aimed at major trading partners, including China, Japan, and the European Union.
The administration has characterized the tariffs as “reciprocal”, asserting they are intended to restore competitive balance in trade relations and incentivize the repatriation of manufacturing and jobs back to the United States. However, economists and investors alike have voiced significant fears that these protectionist policies could trigger widespread inflation and lead to economic stagnation.
Adding to the global trade tensions, China had already responded with retaliatory tariffs on Friday, signaling a potential trade war that could further disrupt international markets and supply chains.
Market Volatility and Recent Declines
The dramatic swings witnessed on April 8 highlight the extreme uncertainty currently gripping the market. The sharp reversal from strong morning gains demonstrated how quickly sentiment can shift based on geopolitical and trade developments.
Broader market declines since President Trump’s tariff announcement have been substantial. Over the previous four trading days leading up to Tuesday, the S&P 500 had fallen 12%, the Dow Jones Industrial Average had dropped 10.8%, and the Nasdaq Composite had declined 13.3%. The S&P 500 now stands nearly 19% below its record high reached in February, putting it firmly in correction territory and approaching bear market levels.
Economic Indicators and Administration Posture
Beyond equities, the bond market also reflected shifting dynamics. The yield on the benchmark 10-year Treasury note rose to 4.29% on Tuesday, an increase from 4.16% the prior day. Rising Treasury yields can impact borrowing costs across the economy, potentially adding another headwind to growth.
White House officials, while not signaling an immediate reversal of the tariff plans, have indicated that negotiations are ongoing with trading partners, including Japan and South Korea. These discussions appear aimed at potentially mitigating the impact or finding alternative resolutions, though the imminent implementation deadline cast a long shadow over hopes for a last-minute breakthrough.
Company News: CVS Posts Gains Amidst Downturn
Amidst the broader market decline, some individual companies reported positive news that buoyed their shares. CVS Health, for example, saw its shares rise about 7% on Tuesday. The increase followed announcements regarding key executive appointments.
The company named Brian Newman, formerly the CFO of UPS, as its new Chief Financial Officer, with his tenure set to begin on April 21. Additionally, Amy Compton-Phillips was appointed as the new Chief Medical Officer, effective May 19. These changes follow a previous leadership transition in October, when David Joyner was appointed as CEO. CVS shares have performed strongly this year, reportedly up about 54% year-to-date as of Tuesday’s close.
However, CVS’s gains were an outlier on a day dominated by tariff-induced selling pressure and high volatility, reflecting the market’s deep apprehension as the midnight deadline for the new tariffs approached.
